Antibe Therapeutics Inc ATE-CA:Toronto Stock Exchange

*Data is delayed | CAD
Last | 06/11/21 EDT
3.82quote price arrow down-0.06 (-1.55%)
Volume
103,294
52 week range
3.05 - 7.52

...

Loading . . .
  • Open3.90
  • Day High3.90
  • Day Low3.75
  • Prev Close3.88
  • 52 Week High7.52
  • 52 Week High Date02/17/21
  • 52 Week Low3.05
  • 52 Week Low Date10/29/20

Key Stats

  • Market Cap122.13M
  • Shares Out38.78M
  • 10 Day Average Volume104,291
  • Dividend-
  • Dividend Yield-
  • Beta0.18
  • YTD % Change-2.8

KEY STATS

  • Open3.90
  • Day High3.90
  • Day Low3.75
  • Prev Close3.88
  • 52 Week High7.52
  • 52 Week High Date02/17/21
  • 52 Week Low3.05
  • 52 Week Low Date10/29/20
  • Market Cap122.13M
  • Shares Out38.78M
  • 10 Day Average Volume104,291
  • Dividend-
  • Dividend Yield-
  • Beta0.18
  • YTD % Change-2.8

RATIOS/PROFITABILITY

  • EPS (TTM)-0.72
  • P/E (TTM)-5.32
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Antibe Therapeutics Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Antibe Therapeutics Inc. is a commercial-stage pharmaceutical company. The Company is focused on pain, inflammation and regenerative medicine. The Company's segments include Antibe Therapeutics, and Citagenix, which is a marketer and distributor of regenerative medicines serving the dental and orthopedic market places. The Company's drug design methodologies involve chemically linking a base drug to its hydrogen sulfide-releasing molecule. Its lead compound, ATB-346, combines...
Walter Macnee
Non-Executive Chairman
Daniel Legault J.D.
President
Alain Wilson
Chief Financial Officer
Scott Curtis
Executive Vice President
Address
15 Prince Arthur Avenue
Toronto, CA
M5R 1B2
Canada

Top Peers

SYMBOLLASTCHG%CHG
HBP
Huttig Building Products Inc
6.12+0.02+0.33%
DMAC
DiaMedica Therapeutics Inc
8.96+0.67+8.08%
CRDL
Cardiol Therapeutics Inc
3.21-0.01-0.31%
IMV
IMV Inc
2.39-0.03-1.24%
ONC